Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Psycho-Oncology|May 14, 2008
Exercise and relaxation intervention for breast cancer survivors: feasibility, acceptability and effectsCarolyn Rabin, Bernardine Pinto, Shira Dunsiger, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|October 21, 2020
Determining meaningful health-related quality-of-life improvement in persons with haemophilia A using the Haemophilia Quality of Life Questionnaire for Adults (Haem-A-QoL)Sylvia von Mackensen, Olivier Catalani, Elina Asikanius, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 24, 2008
Smoking cessation among patients in an emergency chest pain observation unit: outcomes of the Chest Pain Smoking Study (CPSS)Beth C Bock, Bruce M Becker, Raymond S Niaura, et al.Journal of Cancer Survivorship : Research and Practice|February 21, 2026
Understanding the lived experience of colorectal cancer: a qualitative study of patient and clinician perspectivesBarry D Stein, Lois Downes, Nicole Sheahan, et al.Journal of Patient-Reported Outcomes|August 25, 2020
What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?Rachael Lawrance, Evgeny Degtyarev, Philip Griffiths, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|October 21, 2020
Health-related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors-Results from the HAVEN 2 studyMaria Elisa Mancuso, Johnny Mahlangu, Robert Sidonio, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|January 28, 2021
Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitorsChristine Kempton, Peter Trask, Aric Parnes, et al.Research Square|July 10, 2026
Illustrative Integration of Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Data in Dose-Cohort Review for a Phase I Clinical TrialCarolyn Mead-Harvey, Brie Noble, Claire Yee, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 12, 2021
Health-related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors-A non-interventional studyJohannes Oldenburg, Huyen Tran, Flora Peyvandi, et al.Clinical Pharmacology and Therapeutics|April 18, 2025
Oncology Dose Optimization: Tailored Approaches to Different Molecular ClassesJiawen Zhu, Amy Schroeder, Sabine Frank, et al.Pageof 3